NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Conglomerates · USD

Harte Hanks, Inc. (HHS) Stock Analysis

Harte Hanks, Inc. (HHS) is a Conglomerates stock listed on NASDAQ and quoted in US Dollar.

HHS

$4.27

+$0.06 (+1.43%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HHS with… →

HHS Key Statistics

As of Sep 4, 2026
Trading
Open
$4.17
Previous Close
$4.21
Day's Range
4.17–4.28
52-Week Range
2.00–4.50
Volume
49.80K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.09
Valuation
Market Cap
$31.83M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.21
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.78
Financials (FY)
Revenue (FY)
$159.57M−13.86%
Net Income (FY)
−$811.00K
Profit marginThe share of revenue left as profit after all costs and taxes.
−3.70%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
7.45M
1-Year Return
+14.48%
Dividend and dates
Avg Volume
132.73K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HHS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+41.86%
2025−41.55%
2024−24.15%
2023−41.92%
2022+53.82%
2021+176.36%
2020−23.18%
2019+47.93%
2018−74.53%
2017−37.09%
2016 (partial year)−12.72%

As of September 4, 2026.

HHS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$159.57M−$811.00K−0.5%
2024$185.24M−$30.30M−16.4%
2023$191.49M−$1.57M−0.8%
2022$206.28M$36.78M17.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$159.57M$109.67M$2.17M−$811.00K−0.5%
2024$185.24M$128.60M$7.66M−$30.30M−16.4%
2023$191.49M$131.92M$9.05M−$1.57M−0.8%
2022$206.28M$144.35M$15.11M$36.78M17.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HHS Valuation vs Conglomerates Median

Median of 28 stocks
MetricHHSConglomerates medianvs median
P/S ratio0.210.770.3x the median
Profit margin−3.70%2.23%5.9 pts below

Medians across 28 Conglomerates stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Harte Hanks, Inc. (HHS) is capitalised at $31.83M on the latest close. It is classified in the Conglomerates industry, within the Industrials sector. Headcount on file is 1,719.

Over the past 52 weeks the price has ranged from $2.00 to $4.50. The most recent close on file for HHS is $4.27, dated September 4, 2026. That is +$0.06 (+1.43%) against the previous close. The latest close sits 113.5% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $159.57M. Against the prior fiscal year total of $185.24M, that is a change of −13.86%. The same year closed with a net loss of $811.00K. Profit margin runs at −3.7%. That is 5.9 percentage points below the Conglomerates median of 2.23%. Earnings per share on a trailing basis come to −0.78.

Across the 4 fiscal years on file, revenue moves from $206.28M in 2022 to $159.57M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 0.21 times revenue. On price-to-sales that is 0.3 times the Conglomerates median of 0.77. 28 Conglomerates companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.09. Annualized volatility over the trailing 10 years is 65.35%. Over the trailing twelve months the price has returned +14.48%. Measured over 10 years, that is −12.64% a year compounded.

Growth & Income

The record shows no dividend for HHS.

2026 is still running; the price is +41.86% year to date. Across the complete calendar years on file, 2021 returned +176.36% and 2018 returned −74.53%. Of the 9 complete calendar years on file, 3 finished higher.

Peer Comparison

Harte Hanks, Inc. (HHS) operates in the Conglomerates industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Harte Hanks, Inc. HHS $31.83M —
3M Company MMM $86.93B 29.8
Honeywell International Inc. HON $66.43B 8.1
Valmont Industries, Inc. VMI $9.29B 18.8

The Conglomerates industry average P/E ratio is 9.2x. Harte Hanks, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Conglomerates Stocks

MMM

3M Company

$86.93B

 HON

Honeywell International Inc.

$66.43B

 VMI

Valmont Industries, Inc.

$9.29B

 BBUC

Brookfield Business Corporation

$5.76B

 GHC

Graham Holdings Company

$4.81B

 PAM

Pampa Energía S.A.

$4.55B
View all Conglomerates stocks →

Popular Industrials Stocks

SPCX

Space Exploration Technologies Corp.

$1.95T

 CAT

Caterpillar Inc.

$374.15B

 GE

GE Aerospace

$349.78B

 RTX

RTX Corporation

$270.62B

 GEV

GE Vernova Inc.

$250.87B
View all Industrials stocks →

About Harte Hanks, Inc.

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Revenue Solutions, Customer Care, and Fulfillment and Logistics. It offers data and analytics, including audience identification, profiling, segmentation and prioritization, and predictive modeling and data strategy; research and intelligence, helps in understanding of customers, category, competitors, and capabilities; strategy, which plans and executes omnichannel marketing, demand generation, and customer experience programs; creative and content, including creative concepts, messaging and content assets for print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice; marketing technology, a website and app development, e-commerce development and enablement, database building and management, platform architecture creation, and marketing automation; digital and multi-channel marketing execution and advertising; demand generation and account based marketing; and managed marketing services. It also provides product, print-on-demand, and mail fulfillment services, including as printing on demand and distributing literature, managing product recalls, and promotional and branded product distribution; and third-party logistics and freight optimization services. In addition, the company offers inside sales outsourcing, which provides B2B enterprises, and small to midsized businesses with an outsourced sales service; lead generation services; and sales play development, as well as customer service outsourcing, customer care technology and artificial intelligence transformation, and self-service technology. It serves B2B, healthcare, pharmaceuticals, health insurance, consumer, travel, hospitality, streaming, entertainment, quick service restaurants, financial, fintech, automotive, and retail industries. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

Visit website →